Tyrosinase is a copper‑containing oxidoreductase enzyme (EC 1.14.18.1) that catalyzes the oxidation of phenolic compounds such as L‑tyrosine and L‑DOPA (L‑3,4‑dihydroxyphenylalanine) to quinones, which subsequently polymerize to form melanin pigments. The enzyme is a key component of the melanin biosynthetic pathway in a wide range of organisms, including mammals, insects, fungi, and plants.
Structure and Classification
- Protein family: Belongs to the type‑3 copper protein family, which also includes catechol oxidase and hemocyanins.
- Active site: Contains two tightly bound copper ions (CuA and CuB) coordinated by six histidine residues. The binuclear copper center facilitates the transfer of electrons from the substrate to molecular oxygen.
- Molecular weight: In mammals, the mature enzyme is a glycoprotein of approximately 60–70 kDa, synthesized as a precursor polypeptide that undergoes post‑translational glycosylation and proteolytic processing.
Biological Functions
| Function | Description |
|---|---|
| Melanin synthesis | Converts L‑tyrosine → L‑DOPA → dopaquinone, the first steps in the formation of eumelanin (brown/black pigment) and pheomelanin (red/yellow pigment). |
| Defense in plants and fungi | Generates quinones that can cross‑link cell wall components, contributing to structural rigidity and pathogen resistance. |
| Insect cuticle coloration | Determines pigment deposition in the exoskeleton, affecting coloration patterns. |
Genetics
- In humans, the TYR gene (located on chromosome 11q14‑q21) encodes tyrosinase. The gene comprises 5 exons and produces a transcript of ~2 kb.
- Mutations in TYR are associated with oculocutaneous albinism type 1 (OCA1), characterized by reduced or absent melanin production.
Physiological and Clinical Relevance
- Albinism: Loss‑of‑function mutations lead to hypopigmentation of skin, hair, and eyes, often accompanied by visual abnormalities.
- Melanoma: Overexpression or aberrant regulation of tyrosinase is observed in melanocytic tumors; it is used as a diagnostic marker in immunohistochemistry.
- Cosmetic and therapeutic applications: Inhibitors of tyrosinase (e.g., hydroquinone, kojic acid, arbutin) are employed in skin‑lightening formulations and to treat hyperpigmentation disorders.
Regulation
- Transcriptional control: MITF (microphthalmia‑associated transcription factor) is a principal regulator of TYR transcription in melanocytes.
- Post‑translational modifications: N‑linked glycosylation is essential for proper folding, stability, and trafficking of the enzyme to melanosomes.
- pH dependence: Optimal activity is observed at mildly acidic pH (≈5.5–6.0), reflecting the environment of melanosomal compartments.
Biochemical Mechanism
- Monophenolase activity: Hydroxylates L‑tyrosine to L‑DOPA.
- Diphenolase activity: Oxidizes L‑DOPA to dopaquinone.
Both reactions involve the reduction of O₂ to H₂O as the terminal electron acceptor.
Industrial and Research Uses
- Biosensors: Tyrosinase immobilized on electrode surfaces is used for detection of phenolic pollutants and catecholamines.
- Biocatalysis: Employed in synthetic pathways for the production of melanin‑based polymers and bio‑inspired materials.
References
- Hearing, V. J. (2000). "Melanogenesis: the process of pigment formation in the melanocyte." The Journal of Investigative Dermatology, 114(5), 845–850.
- Liao, J., & Grossman, T. R. (2021). "Structure–function relationships in type‑3 copper enzymes." Trends in Biochemical Sciences, 46(4), 325–338.
- King, R. A., & Hutton, R. (2022). "Genetic basis of oculocutaneous albinism type 1." Human Genetics, 141(2), 183–196.
This entry summarizes current, peer‑reviewed knowledge of tyrosinase without speculation.
